229 related articles for article (PubMed ID: 19635748)
1. Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice.
Lin PP; Pandey MK; Jin F; Raymond AK; Akiyama H; Lozano G
Carcinogenesis; 2009 Oct; 30(10):1789-95. PubMed ID: 19635748
[TBL] [Abstract][Full Text] [Related]
2. EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model.
Lin PP; Pandey MK; Jin F; Xiong S; Deavers M; Parant JM; Lozano G
Cancer Res; 2008 Nov; 68(21):8968-75. PubMed ID: 18974141
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
[TBL] [Abstract][Full Text] [Related]
4. p53: functions, mutations and sarcomas.
Hung J; Anderson R
Acta Orthop Scand Suppl; 1997 Feb; 273():68-73. PubMed ID: 9057590
[TBL] [Abstract][Full Text] [Related]
5. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.
Rubio R; Gutierrez-Aranda I; Sáez-Castillo AI; Labarga A; Rosu-Myles M; Gonzalez-Garcia S; Toribio ML; Menendez P; Rodriguez R
Oncogene; 2013 Oct; 32(41):4970-80. PubMed ID: 23222711
[TBL] [Abstract][Full Text] [Related]
6. Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency.
Choi J; Curtis SJ; Roy DM; Flesken-Nikitin A; Nikitin AY
Am J Pathol; 2010 Nov; 177(5):2645-58. PubMed ID: 20864684
[TBL] [Abstract][Full Text] [Related]
7. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin.
Harvey M; Vogel H; Lee EY; Bradley A; Donehower LA
Cancer Res; 1995 Mar; 55(5):1146-51. PubMed ID: 7867001
[TBL] [Abstract][Full Text] [Related]
8. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
[TBL] [Abstract][Full Text] [Related]
9. Status of the p53, Rb and MDM2 genes in canine osteosarcoma.
Mendoza S; Konishi T; Dernell WS; Withrow SJ; Miller CW
Anticancer Res; 1998; 18(6A):4449-53. PubMed ID: 9891508
[TBL] [Abstract][Full Text] [Related]
10. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas.
Wunder JS; Czitrom AA; Kandel R; Andrulis IL
J Natl Cancer Inst; 1991 Feb; 83(3):194-200. PubMed ID: 1988704
[TBL] [Abstract][Full Text] [Related]
11. Coamplification of Myc/Pvt1 and homozygous deletion of Nlrp1 locus are frequent genetics changes in mouse osteosarcoma.
Rao PH; Zhao S; Zhao YJ; Yu A; Rainusso N; Trucco M; Allen-Rhoades W; Satterfield L; Fuja D; Borra VJ; Man TK; Donehower LA; Yustein JT
Genes Chromosomes Cancer; 2015 Dec; 54(12):796-808. PubMed ID: 26355645
[TBL] [Abstract][Full Text] [Related]
12. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage.
Berman SD; Calo E; Landman AS; Danielian PS; Miller ES; West JC; Fonhoue BD; Caron A; Bronson R; Bouxsein ML; Mukherjee S; Lees JA
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11851-6. PubMed ID: 18697945
[TBL] [Abstract][Full Text] [Related]
13. Osteosarcoma cell lines display variable individual reactions on wildtype p53 and Rb tumour-suppressor transgenes.
Hellwinkel OJ; Müller J; Pollmann A; Kabisch H
J Gene Med; 2005 Apr; 7(4):407-19. PubMed ID: 15538723
[TBL] [Abstract][Full Text] [Related]
14. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
Stratton MR; Moss S; Warren W; Patterson H; Clark J; Fisher C; Fletcher CD; Ball A; Thomas M; Gusterson BA
Oncogene; 1990 Sep; 5(9):1297-301. PubMed ID: 2216456
[TBL] [Abstract][Full Text] [Related]
15. Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo.
Rubio R; García-Castro J; Gutiérrez-Aranda I; Paramio J; Santos M; Catalina P; Leone PE; Menendez P; Rodríguez R
Cancer Res; 2010 May; 70(10):4185-94. PubMed ID: 20442289
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas.
Watanabe H; Shimokado K; Asahara T; Dohi K; Niwa O
Jpn J Cancer Res; 1999 Jan; 90(1):40-7. PubMed ID: 10076563
[TBL] [Abstract][Full Text] [Related]
17. Cooperative tumorigenic effects of germline mutations in Rb and p53.
Williams BO; Remington L; Albert DM; Mukai S; Bronson RT; Jacks T
Nat Genet; 1994 Aug; 7(4):480-4. PubMed ID: 7951317
[TBL] [Abstract][Full Text] [Related]
18. Cancer risks from germ line tumor suppressor gene mutations.
Frebourg T; Malkin D; Friend S
Princess Takamatsu Symp; 1991; 22():61-70. PubMed ID: 1844252
[TBL] [Abstract][Full Text] [Related]
19. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.
Toguchida J; Yamaguchi T; Ritchie B; Beauchamp RL; Dayton SH; Herrera GE; Yamamuro T; Kotoura Y; Sasaki MS; Little JB
Cancer Res; 1992 Nov; 52(22):6194-9. PubMed ID: 1423262
[TBL] [Abstract][Full Text] [Related]
20. Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA.
Mutsaers AJ; Ng AJ; Baker EK; Russell MR; Chalk AM; Wall M; Liddicoat BJ; Ho PW; Slavin JL; Goradia A; Martin TJ; Purton LE; Dickins RA; Walkley CR
Bone; 2013 Jul; 55(1):166-78. PubMed ID: 23486187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
